Title  | Date  | Price |
|---|
Directory of Top 60 Biopharmaceutical Manufacturers in INDIA
| Sep 2008 |
£860 |
Biotechnology
| Sep 2008 |
£870 |
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
| Sep 2008 |
£2,305 |
European Biosimilars Market Outlook
| Sep 2008 |
£3,910 |
Freedonia Focus on Biologicals
| Sep 2008 |
£310 |
U.S. Stem Cell Market - Current Development
| Sep 2008 |
£3,605 |
Who's Developing What in Global Biopharmaceuticals?
Biopharmaceuticals, Pharmaceuticals, Healthcare, Company, Market
| Sep 2008 |
£695 |
Successful Pharmabiotech Alliance Strategies
Driving Synergies, Avoiding Failure and Managing Relationships
| Sep 2008 |
£2,305 |
Medical Nanotechnology Markets
| Sep 2008 |
£2,105 |
China Pharmaceutical & Biotechnology Monthly
| Sep 2008 |
£1,200 |
Practical Systems Biology
Demonstrating Value Today in Pharma R&D
| Aug 2008 |
£900 |
Baylor Health Care System - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Providence Health System - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
New York City Health and Hospitals Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Spectrum Health System - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
MedCath Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Group Health Cooperative - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Sutter Health - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Inova Health System - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Cml Healthcare Income Fund - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Clarian Health Partners, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Christus Health - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Catholic Healthcare Partners - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Southern Cross Healthcare Group Plc - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Stille Ab - Healthcare - Medical Equipment
SWOT Report
| Aug 2008 |
£77 |
LifePoint Hospitals, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
XCounter Ab - Healthcare - Medical Equipment
SWOT Report
| Aug 2008 |
£77 |
Xceed Biotechnology Limited - Healthcare - Medical Equipment
SWOT Report
| Aug 2008 |
£77 |
Sisters of Mercy Health System - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Hip Health Plan of New York - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Jefferson Health System, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
NewYork- Presbyterian Hospital - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Ramsay Health Care Limited - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Mayo Foundation for Medical Education and Research - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Intermountain Healthcare, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
Catholic Health Services of Long Island - Healthcare - Managed Care and Hospitals
SWOT Report
| Aug 2008 |
£77 |
U.S. Human Growth Hormone Market
| Aug 2008 |
£3,605 |
Viropharma Incorporated: Strategic Corporate Assessment
Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
| Aug 2008 |
£300 |
Cubist Pharmaceuticals Inc
Strategic Corporate Assessment Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
| Aug 2008 |
£300 |
Boehringer Ingelheim GmbH: PharmaVitae Profile
| Aug 2008 |
£3,475 |
Eli Lilly & Co.: PharmaVitae Profile
| Aug 2008 |
£3,475 |
Spectrum Surgical Instruments Corporation Medical Equipment
Company Share Analysis
| Jul 2008 |
£620 |
Shofu Inc. Medical Equipment
Company Share Analysis
| Jul 2008 |
£620 |
Karl Storz Gmbh & Co. Kg Medical Equipment
Company Share Analysis
| Jul 2008 |
£620 |
Medikro Oy. Medical Equipment
Company Share Analysis
| Jul 2008 |
£620 |
Ontex International N.V. Medical Equipment
Company Share Analysis
| Jul 2008 |
£620 |
DNA Sequencing and PCR Markets
| Jul 2008 |
£2,105 |
Biopharmaceuticals in South East Asia
| Jul 2008 |
£795 |
Microscopy Markets
| Jul 2008 |
£2,105 |
SNP Genotyping and Analysis Markets
| Jun 2008 |
£2,400 |
Booming Biotech Market in India
| Jun 2008 |
£840 |
Technologies for SNP Detection and Mapping (Technical Insights)
| Jun 2008 |
£3,910 |
Emerging Technologies in Systems Biology (Technical Insights)
| Jun 2008 |
£3,910 |
Bioplastics Markets in Southeast Asia
| Jun 2008 |
£3,605 |
U.S. Rapid Microbiology Tests Markets
| Jun 2008 |
£3,605 |
Monoclonal Antibodies Report
| Jun 2008 |
£4,635 |
Strategic Assessment of North American Healthcare Biometrics Markets
| Jun 2008 |
£1,805 |
U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
| May 2008 |
£3,605 |
Automated and Rapid Microbiological Tests
| May 2008 |
£2,375 |
Genomics World Markets
| May 2008 |
£2,105 |
Bioinformatics
| May 2008 |
£2,675 |
Magellan Health Svcs.: Corporate Analysis
| May 2008 |
£240 |
Ferrellgas Partners: Corporate Analysis
| May 2008 |
£240 |
Amphenol: Corporate Analysis
| May 2008 |
£240 |
Sunrise Senior Living: Corporate Analysis
| May 2008 |
£240 |
AMC Entertainment: Corporate Analysis
| May 2008 |
£240 |
Cabela's: Corporate Analysis
| May 2008 |
£240 |
UST: Corporate Analysis
| May 2008 |
£240 |
Nextel Partners: Corporate Analysis
| May 2008 |
£240 |
Applera: Corporate Analysis
| May 2008 |
£240 |
Medical Mutual of Ohio: Corporate Analysis
| May 2008 |
£240 |
Rush Enterprises: Corporate Analysis
| May 2008 |
£240 |
Maverick Tube: Corporate Analysis
| May 2008 |
£240 |
Polaris Industries: Corporate Analysis
| May 2008 |
£240 |
Superior Essex: Corporate Analysis
| May 2008 |
£240 |
Arkansas Best: Corporate Analysis
| May 2008 |
£240 |
William Lyon Homes: Corporate Analysis
| May 2008 |
£240 |
Quanta Services: Corporate Analysis
| May 2008 |
£240 |
Pacer International: Corporate Analysis
| May 2008 |
£240 |
Tecumseh Products: Corporate Analysis
| May 2008 |
£240 |
Symbol Technologies: Corporate Analysis
| May 2008 |
£240 |
Las Vegas Sands: Corporate Analysis
| May 2008 |
£240 |
NII Holdings: Corporate Analysis
| May 2008 |
£240 |
Marsh Supermarkets: Corporate Analysis
| May 2008 |
£240 |
Cleveland-Cliffs: Corporate Analysis
| May 2008 |
£240 |
Service Corp. Intl.: Corporate Analysis
| May 2008 |
£240 |
JLG Industries: Corporate Analysis
| May 2008 |
£240 |
Church & Dwight: Corporate Analysis
| May 2008 |
£240 |
NBTY: Corporate Analysis
| May 2008 |
£240 |
Cenveo: Corporate Analysis
| May 2008 |
£240 |
Deluxe: Corporate Analysis
| May 2008 |
£240 |
King Pharmaceuticals: Corporate Analysis
| May 2008 |
£240 |
Toro: Corporate Analysis
| May 2008 |
£240 |
Quiksilver: Corporate Analysis
| May 2008 |
£240 |
C.R. Bard: Corporate Analysis
| May 2008 |
£240 |
Dow Jones: Corporate Analysis
| May 2008 |
£240 |
IMS Health: Corporate Analysis
| May 2008 |
£240 |
Newfield Exploration: Corporate Analysis
| May 2008 |
£240 |
Indymac Bancorp: Corporate Analysis
| May 2008 |
£240 |
Guitar Center: Corporate Analysis
| May 2008 |
£240 |
first
previous
